Literature DB >> 27030388

Two cases of cyclic neutropenia with acquired CSF3R mutations, with 1 developing AML.

Maksim Klimiankou1, Sabine Mellor-Heineke2, Olga Klimenkova1, Elisa Reinel1, Murat Uenalan3, Siarhei Kandabarau2, Julia Skokowa1, Karl Welte4, Cornelia Zeidler2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27030388     DOI: 10.1182/blood-2015-12-685784

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

Review 1.  Severe congenital neutropenias.

Authors:  Julia Skokowa; David C Dale; Ivo P Touw; Cornelia Zeidler; Karl Welte
Journal:  Nat Rev Dis Primers       Date:  2017-06-08       Impact factor: 52.329

2.  A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.

Authors:  Yaling Qiu; Yangyang Zhang; Nan Hu; Fan Dong
Journal:  J Biol Chem       Date:  2017-01-10       Impact factor: 5.157

3.  Diagnosis and therapeutic decision-making for the neutropenic patient.

Authors:  James A Connelly; Kelly Walkovich
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 4.  Identification of novel MECOM gene fusion and personalized therapeutic targets through integrative clinical sequencing in secondary acute myeloid leukemia in a patient with severe congenital neutropenia: a case report and literature review.

Authors:  James A Connelly; Rajen J Mody; Yi-Mi Wu; Dan R Robinson; Robert J Lonigro; Pankaj Vats; Erica Rabban; Bailey Anderson; Kelly Walkovich
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-04-02

Review 5.  Assessment of Congenital Neutropenia in Children: Common Clinical Sceneries and Clues for Management.

Authors:  Ilaria Lazzareschi; Elena Rossi; Antonietta Curatola; Giovanna Capozio; Luca Benacquista; Ludovica Iezzi; Donato Rigante
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-01-01       Impact factor: 2.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.